Summary. Acute insulin-induced hypoglycaemia in humans provokes autonomic neural activation and counterregulatory hormonal secretion mediated in part via hypothalamic stimulation. Many patients with Type I (insulin-dependent) diabetes have acquired deficiencies of counterregulatory hormonal release following hypoglycaemia. To study the integrity of the hypothalamic-pituitary and the sympatho-adrenal systems, the responses of pituitary hormones, beta-endorphin, glucagon and adrenaline to acute insulin-induced hypoglycaemia (0.2 units/kg) were examined in 16 patients with Type l diabetes who did not have autonomic neuropathy. To examine the effect of duration of diabetes these patients were subdivided into two groups (Group 1:8 patients<5 years duration; Group 2:8 patients > 15 years duration) and were compared with 8 normal volunteers (Group 3). The severity and time of onset of hypoglycaemia were similar in all 3 groups, but mean blood glucose recovery was slower in the diabetic groups (p <0.01). The mean responses of glucagon, adrenaline, adrenocorticotrophic hormone, prolactin and beta-endorphin were similar in all 3 groups, but the mean responses of growth hormone were lower in both diabetic groups than in the normal group (p < 0.05). The mean increments of glucagon and adrenaline in the diabetic groups were lower than the normal group, but these differences did not achieve significance; glucagon secretion was preserved in several diabetic patients irrespective of duration of disease. Various hormonal responses to hypoglycaemia were absent or diminished in individual diabetic patients, and multiple hormonal deficiencies could be implicated in delaying blood glucose recovery. The demonstration of subnormal secretion of adrenaline and pituitary hormones following hypoglycaemia in individual patients supports the concept that central (hypothalamic) activation of counterregulation may be diminished in Type 1 diabetes.
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Acute insulin-induced hypoglycaemia in man stimulates the release of several hormones, some of which contribute to glucose counterregulation. The integrated counterregulatory response in primates is thought to be initiated centrally within the hypothalamus [1] , with simultaneous activation of the autonomic centres and the hypothalamic-pituitary system. The profound sympatho-adrenal response with secretion of catecholamines is accompanied by the release of prolactin, adrenocorticotrophic hormone (ACTH) and growth hormone from the anterior pituitary gland, and also of the opioid peptide, beta-endorphin [2] , which shares a common precursor with ACTH [3] . Glucagon secretion following acute hypoglycaemia occurs independently of autonomic stimulation and hypothalamic control [4] .
Deficiencies of various counterregulatory hormonal responses to acute hypoglycaemia occur in patients with Type 1 (insulin-dependent) diabetes, the dual failure of glucagon and adrenaline secretion being implicated in the impairment of blood glucose recovery [5] . The secretion of adrenaline in response to hypoglycaemia appears to diminish with increasing duration of diabetes, and may be caused by autonomic neuropathy [6] . Because the sympatho-adrenal response depends upon activation of central autonomic centres, the concurrent secretion of pituitary hormones in response to acute hypoglycaemia provides an indicator of hypothalamic activation, irrespective of the minimal role which these pituitary hormones may have in rapid glucose counterregulation. To assess the functional integrity of the hypothalamic centre which activates counterregulation the secretory responses to acute hypoglycaemia of adrenaline, pituitary hormones and beta-endorphin were examined in patients with Type 1 diabetes of varying duration, who had no evidence of peripheral autonomic neuropathy. 
Subjects and methods
Permission for the study was granted by the local medical ethical advisory committee, and informed consent was obtained from all participants. Sixteen patients with Type 1 diabetes were recruited from the Diabetic Clinic, Western Infirmary/G',u'tnavel General Hospital, Glasgow and clinical characteristics are shown in Table 1 . None of the subjects was taking any medication and all had a normal body mass index (BMI). The diabetic patients were subdivided into two groups depending on duration of diabetes: The diabetic patients all had good glycaemic control, with glycated haemoglobin values of less than 10%, and the absence of residual endogenous secretion of insulin was determined by measurement of plasma C-peptide both fasting and in response to 1 mg of intravenous glucagon [7] . None of the diabetic patients gave historical evidence of hypoglycaemic unawareness, nor had experienced recent symptoms or episodes of hypoglycaemia.
The diabetic patients were all screened for the presence of complications. Autonomic neural function was evaluated using a group of tests of cardiovascular reflexes [8] to ensure that patients with autonomic dysfunction were not included. This was verified by demonstrating a normal rise of plasma pancreatic polypeptide following hypoglycaemia [9] which was defined as a peak value greater than 40 pmol/l (Table 1) . Mild background diabetic retinopathy (less than 3 microaneurysms/fundus) was observed in 3 patients by direct ophthalmoscopy and none of the diabetic patients had clinical evidence of peripheral neuropathy. None of the patients had an increased excretion of urinary albumin on testing with a simple latex agglutination test, Albuscreen (Cambridge Life Sciences, Cambridge, UK) [101.
Protocol
The diabetic patients were treated for one week with continuous subcutaneous insulin infusion (CSII) using a Betatron 1 pump (Eli Lilly & Co Ltd, Basingstoke, UK) to optimize glycaemic control before the acute hypoglycaemic study was performed. Care was taken to avoid hypoglycaemia during this period and routine home blood glucose monitoring included nocturnal measurements. After an overnight fast, each subject was maintained supine, an indwelling teflon cannula was inserted into an antecubital vein and kept patent with 0.9% saline. The subcutaneous insulin infusion was stopped 15 min before basal sampling of venous blood. To ensure a rapid fall in blood glucose to below 2.0 mmol/1, a large dose of short-acting, soluble insulin (Actrapid-MC, Novo Laboratories Ltd, Basingstoke, UK; 0.2 U/kg body weight) was given as an i.v. bolus injection, and the time to the onset of the acute autonomic reaction (R) to hypoglycaemia was recorded; in all subjects R coincided with the nadir of blood glucose, and was manifested by an abrupt rise in heart rate and the onset of autonomic symptoms. Frequent monitoring of blood glucose was performed during the induction of hypoglycaemia using a Reflolux II glucometer (Boehringer Corporation (London) Ltd, Lewes, UK) to assist determination of the blood glucose nadir in each subject. Because of individual variation in the time of onset of R after the administration of i.v. insulin, subsequent serial blood sampling was timed from R until R+ 180 min. Plasma was separated immediately and stored at -20 ~ Blood glucose was measured using a hexokinase method with the Cobas Bio analyser (Roche Diagnostica, Basel, Switzerland). Glycated haemoglobin (HbA1) was measured by gel-electrophoresis. Insulin antibodies were measured using a microenzyme-linked immunosorbent assay [11] . Plasma growth hormone was measured by a double antibody radioimmunoassay, standardised against the first international reference preparation of growth hormone (MRC 66/217) and plasma adrenaline by a radioenzymatic assay [12] . Plasma pancreatic polypeptide [13] , ACTH [14] , prolactin [15] and glucagon (C-terminal glucagon-like immunoreactivity) [16] were measured by radioimmunoassays and plasma beta-endorphin by a sensitive, disequilibrium radioimmunoassay standardised against synthetic human beta-endorphin following affinity gel extraction (Immuno Nuclear Corporation, Stillwater, Minn, USA). The crossreactivity with beta-lipotropin was less than 5%.
Despite the long-established use of the insulin tolerance test in endocrinological investigation, a normal range of hormonal increments to acute insulin-induced hypoglycaemia has rarely been defined in published reports. To interpret the hormonal responses to hypoglycaemia of individual diabetic patients, the normal magnitude of hormonal increments was determined arbitrarily by the lowest maximal increment observed in the individual subjects of the normal group. A delayed blood glucose recovery from hypoglycaemia was defined as a blood glucose concentration of less than 2.0 mmol/1 at R+120 rain. "Normal" responses to hypoglycaemia were defined for individual hormones: adrenaline as a peak concentration above 2.5 nmol/I, prolactin as a peak concentration greater than 600 mU/l, ACTH as a peak concentration greater than 30 mU/l, and growth hormone as a peak concentration greater than 40 mU/l, the latter being of similar magnitude to the growth hormone responses derived from insulin stress tests which used an insulin dose of 0.15 U/kg body weight [171.
Statistical analysis
Results are expressed as mean+SEM, and statistical differences were examined using analyses of variance, providing tests of significance between the three groups. Where significant differences in mean responses were found, these were examined further using Student's t-test for unpaired data. The times to onset of the acute hypoglycaemic reaction (R) were compared using the Mann-Whitney U Test. Correlation coefficients were calculated using the method of provisional means.
Results
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TIME(win) Fig. 1 . Mean blood glucose changes during hypoglycaemia. Changes in mean blood glucose in response to insulin-induced hypoglycaemia in normal, non-diabetic subjects (hatched area, mean + SEM) and in diabetic patients, less than 5 years (I) and greater than 15 years ( 9 ) duration. Insulin was given at time 0 and R denotes acute autonomic reaction poglycaemia was delayed in both diabetic groups compared to the normal group (p<0.01 at all times of measurement from R+ 15 min). No significant differences in blood glucose recovery were found between the two diabetic groups at all times of measurement (Fig.l ). An impaired recovery of blood glucose was observed in one patient in Group 1, and in five patients in Group 2.
All subjects developed objective evidence of an acute hypoglycaemic reaction (R) with an increase in heart rate, sweating and moderate neuroglycopenia. The latter was more pronounced and persisted for longer in four of the diabetic patients (No.'s 5, 11, 14, 16; see Table 1 ). None of the diabetic patients had overt hypoglycaemic unawareness during the study. No significant differences were observed in the mean times from i.v. injection of insulin to the onset of the acute autonomic reaction between any of the three groups; 36 min for Group 1, 33 min for Group 2 and 30 rain for Group 3. 
Prolactin
Plasma prolactin rose from a basal value of 257+ 39mU/l (mean +-SEM) to a maximum of 1176+-131 mU/l at R+30 min in the normal group (t7 <0.01 compared to basal). Similar mean responses were found in both diabetic groups but the peak responses were temporally delayed, particularly in Group 1 (Fig.2) . Although the maximal value was lowest in Group 2, (Type 1 diabetes >15 years duration) this difference was not statistically significant from the other groups. The individual responses of prolactin rose to a value grater than 600 mU/1 in all normal subjects in Group 3, but the increments were reduced or absent in 3 diabetic patients in Group I and in 4 in Group 2 (Fig.3) .
Adrenocorticotrophic hormone
In the normal subjects (Group 3), the mean plasma ACTH rose to 35+_8 mU/l at R+30 min in response to hypoglycaemia (p<0.01 compared to basal). The peak values of plasma ACTH in the two diabetic groups did not differ significantly from Group 3, rising to 31_.+8mU/l in Group1 and to 38+8mU/1 in Group2 (Fig.2 ). An ACTH increment (peak> 30 mU/I) occurred in all of the normal subjects during hypoglycaemia, but a diminished response was observed in three diabetic subjects in Group l and in three in Group 2 (Fig. 3) .
Growth hormone
In the normal group (Group 3) the mean concentration of plasma growth hormone (GH) rose to 125+ (Fig.2) . The increase of plasma GH in both diabetic groups was significantly lower with peak values of 41 +7 mU/I in Group 1, and 57+7 mU/l in Group 2 at R + 30 rain (p < 0.05 compared to Group 3). A normal GH response to hypoglycaemia (peak > 40 mU/l) occurred in all of the non-diabetic subjects, but the GH response was generally lower in all the diabetic subjecLs and was subnormal in 4 patients of Group 1 and in 2 of Group 2 (Fig.3) .
Beta-Endorphin
In the normal group (Group 3) a rise in plasma betaendorphin occurred in response to hypoglycaemia, from a basal value of 5.0+1.2pmol/1 to 7.6+ 1.0 pmol/1 at R, and to 19.5+3.8 pmol/1 at R+30 min (Fig. 4) . In the diabetic groups the mean concentrations were lower at R+30min with values of 12.1_+ 2.4pmol/1 in Group1 and 11.4_+1.7pmol/1 in Group 2, but these differences did not achieve statistical significance when compared with Group 3. The lower limit of a normal individual response to hypoglycaemia was defined arbitrarily as a peak value above 10 pmol/1. Using this value, the beta-endorphin response was reduced in 4 patients in Group I and in 5 in Group 2 (Fig.4) .
Adrenaline
Basal concentrations of plasma adrenaline were similar in all three groups. The peak response of plasma adrenaline occurred at R+30 min in all groups with the highest mean value occurring in the normal group (Group 3) of 5.6___ 1.0 nmol/l (p < 0.02 compared to basal). The peak responses in both diabetic groups were lower at 4.3 + 0.8 nmol/1 in Group 1 and 3.7___ 0.8 nmol/l in Group 2, but these values were not significantly different from the normal response (Fig. 5) .
Using the arbitrarily defined "normal" response for adrenaline, two diabetic patients were subnormal in Group 1, and 3 in Group 2 (Fig,6 ). No significant correlation was found between the maximal adrenaline concentration and the peak values of prolactin, ACTH, GH or beta-endorphin in any of the groups.
Glucagon
The mean responses of plasma glucagon to acute hypoglycaemia are shown in Figure 5 . The peak response occurred at R+30 min in all three groups and although higher in the normal group the differences with the diabetic groups did not achieve statistical sign[f[- cance. The maximal increments of individual subjects are shown in Figure 6 . The pattern of glucagon response was examined in preference to the absolute values, and was absent or subnormal in 2 diabetic patients in Group 1 and in 3 in Group 2, while remaining intact in all other diabetic patients irrespective of the duration of diabetes. The frequency of subnormal or absent responses to hypoglycaemia of individual hormones and beta-endorphin in the diabetic patients is shown in Table 2 . The diabetic patients with delayed recovery of blood glucose (No?s 3, 9-12, 14) appeared to have multiple deficiencies of hormonal secretion in response to hypoglycaemia in comparison with other patients.
Discussion
Activation of the sympatho-adrenal system is a major feature of the response to acute hypoglycaemia in humans [18] . This is thought to be initiated within the autonomic centres in the hypothalamus [1] ; the resulting autonomic neural stimulation and release of catecholamines provoke many of" the classical symptoms of hypoglycaemia. Glucose counterregulation is mediated principally by glucagon and adrenaline [5] , the secretion of both of which can become deficient in patients with Type 1 diabetes and may impair blood glucose recovery [5, 19] . The pituitary hormones appear to have a subservient role in short-term glucose counterregulation, but the magnitude of hormonal secretion by the pituitary gland following hypoglycaemia provides an index of preceding hypothalamic activation. In the absence of peripheral autonomic neuropathy, a blunted hypothalamic response to hypoglycaemia might underlie the reduced release of catecholamines observed in patients with Type 1 diabetes of long duration [6] . Mean responses can mask abnormal hormonal secretion in individual subjects, so the increments of each hormone from basal to peak values were examined in Table 2 . Impaired blood glucose recovery, following hypoglycaemia and subnormal hormonal responses (~) in individual Type I diabetic pat- Total (%) 6 (38%) 5 (31%) 5 (31%) 6 (38%) 6 (38%) 7 (44%) 9 (56%) the present investigation to identify subnormal or absent responses to hypoglycaemia in individual diabetic patients.
In the present study the recovery of blood glucose in both diabetic groups was significantly delayed compared with the normal group. Attenuated recovery of blood glucose after hypoglycaemia in individual diabetic patients was more common in those with longstanding diabetes and presumably was related to diminished secretion of glucagon and/or adrenaline, although these patients also appeared to have a greater frequency of hormonal deficiencies to hypoglycaemic stress. Neither the delayed recovery of blood glucose nor the subnormal adrenaline responses in individual diabetic patients could be attributed to autonomic neuropathy, which was excluded by formal testing of cardiovascular reflexes and by demonstrating a normal rise of plasma pancreatic polypeptide following hypoglycaemia in all subjects [9] . No correlation was observed between the maximum adrenaline and pancreatic polypeptide responses in both diabetic groups, which precluded the possibility that patients with subnormal adrenaline secretion had subclinical autonomic neuropathy [20] . Although raised titres of insulin antibodies in diabetic patients may cause protracted hypoglycaemia by altering the pharmacokinetics of insulin [21, 22] , in the present study the titre of insulin antibodies was markedly elevated in only three diabetic patients (No.'s 10, 13, 14) , all of whom had diabetes of longer duration. Two of these individuals had delayed blood glucose recovery, but also had multiple subnormal responses of counterregulatory hormones.
Glucagon secretion following hypoglycaemia occurs independently of hypothalamic and autonomic neural stimulation but pancreatic alpha cell sensitivity to glucopenia appears to decline with duration of diabetes [4] [5] [6] . Most individual diabetic patients in the present study, including many of long duration, retained the capacity to secrete glucagon in response to a profound hypoglycaemic stimulus, which contradicts the view that total failure of glucagon secretion to this stress is inevitable within a few years of the development of diabetes [5, 6] . Stimulation of a secretory response from diabetic pancreatic alpha cells may depend upon the degree of hypoglycaemia achieved or the method of induction with a large bolus dose of intravenous insulin, in comparison with previous studies in which insulin was administered in lower dosage by a slower intravenous infusion. The present study indicates that a secretory response of glucagon will occur in many patients with diabetes of long duration if the hypoglycaemic stimulus is of sufficient severity.
The mean responses of growth hormone were lower in both groups of diabetic patients following hypoglycaemia, and may be of functional importance to impaired glucose counterregulation in prolonged hypoglycaemia [23] . No significant reductions were observed however in the mean responses of prolactin and ACTH, and the reason for this dissociation with growth hormone is not clear. It may represent develop-ment of selective hypothalamic insensitivity for pituitary hormonal secretion, as the secretion of growth hormone and adrenaline in Type 1 diabetic patients was diminished following hypoglycaemia but was normal in response to exercise [24] , indicating that the magnitude of hormonal secretion is stimulus-dependent. However, diminished responses to hypoglycaemia of growth hormone [24] [25] [26] and cortisol [27, 28] have been described previously in patients with Type 1 diabetes, and another study demonstrated plasma increments of growth hormone, cortisol and adrenaline which were inappropriately low for the prevailing degree of hypoglycaemia [21] . A few diabetic patients with recurrent clinical hypoglycaemia and impaired blood glucose recovery have been described who have multiple deficiencies of counterregulatory hormones, including growth hormone and ACTH, in response to hypoglycaemia [29, 30] .
The precise functional importance of pituitary hormonal deficiencies to glucose counterregulation is unclear, but the demonstration of single or multiple subnormal responses in individual diabetic patients suggests some form of hypothalamic dysfunction, without the development of overt pituitary or adrenal failure. Alternatively, the blood glucose concentration at which hypothalamic-pituitary secretion is stimulated may be lower than normal in these individuals. The glycaemic threshold for the release of cortisol is lower than that for growth hormone or adrenaline [31] , which implies that a lower blood glucose is necessary to stimulate ACTH release than the other hormones secreted via hypothalamic-pituitary activation. In the present study the degree of hypoglycaemia achieved was of similar severity in the diabetic patients and the normal subjects, so the subnormal ACTH secretion observed in 6 diabetic patients was unlikely to be related to the absolute blood glucose concentration. Furthermore, the administration of a large dose of insulin ensured a rapid fall in blood glucose which remained low for a longer time in the diabetic patients; this protracted stimulus should augment rather than diminish counterregulatory hormonal secretion. Reduced central activation of the hypothalamus following hypoglycaemia would explain the subnormal pituitary hormonal responses of the individual diabetic patients in the present study.
Beta-endorphin is present in high concentration in the hypothalamus, is implicated in the regulation of hypothalamic-pituitary responses to stress [32] , and in humans is released in response to hypoglycaemia from the anterior pituitary gland [2] . The counterregulatory role of beta-endorphin following hypoglycaemia is unknown in normal humans; its release in this situation has not been reported previously in diabetic patients. The content of beta-endorphin in the hypothalamus and anterior pituitary gland is reduced in insulin-dependent diabetic rats [33] . Subnormal responses of beta-endorphin to hypoglycaemia in individual diabetic patients in the present study suggests a possible reduction in hypothalamic-pituitary beta-endorphin in human Type 1 diabetes, and is consistent with the concept of underlying hypothalamic dysfunction or reduced activation in some patients.
The quality of preceding glycaemic control may influence the threshold at which the hypothalamus responds to a hypoglycaemic stimulus [34] . Intensive insulin therapy for several months has been shown to influence hormonal counterregulatory responses to hypoglycaemia in diabetic patients, producing a quantitative reduction in the responses of growth hormone, cortisol and adrenaline [35] . Similarly the glycaemic threshold for the secretion of adrenaline was lowered in Type I diabetic patients by preceding optimal glycaemic control [36] , and the perception of hypoglycaemic symptoms was decreased [37] . All, of our patients had good glycaemic control as measured by glycated haemoglobin, and this may have influenced the threshold of the counterregulatory hormonal responses to hypoglycaemia. Similarly, the maintenance of normoglycaemia using CSII, albeit for only a few days, may have reduced the magnitude of the hypothalamic-pituitary response to hypoglycaemia. The rapidity with which the central nervous system can adapt to prevailing glycaemia is unknown but an apparent hypothalamic insensitivity to hypoglycaemia might result from transient modification of glucose receptor function within the brain or of glucose transport across the blood-brain barrier [38] . Such a phenomenon might underlie the variability of counterregulatory hormonal responses to hypoglycaemia in individual patients with Type 1 diabetes.
